RUO‘ZENLog in
Stocks › Healthcare › MBX

MBX Biosciences stockMBX

MBX Biosciences Inc · Nasdaq
$48.46
−7.66% on the day
close Nov 5, 2026
What is happening with the stock

MBX Biosciences trades at $48.46, 33.3% below its 52-week high (Aug 5, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +53.6% year to date, +114.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.

Closing price, 6 monthsdetailed chart in the terminal
28.4250.8973.3752-week high 72.64May 8, 2026Nov 5, 2026

Ratings, candles, signals and the screener for MBX — after you log in

Open the terminal
From 52-week high−33.3%
High72.64 Aug 5, 2026
vs 50-day avg−14.5%
vs 200-day avg+5.8%
Year to date+53.6%
12 months+114.9%
Dividend yieldnone
EarningsNov 5
Market cap$2.3B
Chart patternconsolidation
Exchange · sinceNasdaq · 2024

Frequently asked questions about MBX Biosciences

What is the MBX Biosciences stock price?

At the close on Nov 5, 2026: $48.46 (−7.66% on the day). 52-week high: $72.64 on Aug 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does MBX Biosciences report earnings?

The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −34% year over year, revenue 0%.

Does MBX Biosciences pay dividends?

No, MBX Biosciences does not pay dividends.

Where does MBX Biosciences trade and how to buy it?

Ticker MBX, exchange Nasdaq, listed since 2024. You can buy it through a broker with access to US exchanges.

Should I buy MBX Biosciences now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for MBX are in the terminal after you log in.

Similar stocks

More on MBX

Included in lists